Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica

Acta Neurologica Belgica

Volumn 115, Issue 4, 2015, Pages 609-614

  Farrokhi, Mehrdad ^a,b   Rezaei, Ali ^c   Amani Beni, Ali ^a,b   Etemadifar, Masoud ^a,b   Kouchaki, Ebrahim ^d   Zahedi, Abolfazl ^d  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Multiple Sclerosis and Neuroimmunology Research Center   (Iran)

^c BROWN UNIVERSITY   (United States)

^d KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ELISA; Inflammation; Interleukin 37 (IL 37); Multiple sclerosis; Neuromyelitis optica

Indexed keywords

INTERLEUKIN 37; IL37 PROTEIN, HUMAN; INTERLEUKIN 1;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; BLOOD; DISABILITY; MIDDLE AGED; STATISTICS;

ADULT; CASE-CONTROL STUDIES; DISABILITY EVALUATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; STATISTICS AS TOPIC;

EID: 84947493546     PISSN: 03009009     EISSN: 22402993     Source Type: Journal    
DOI: 10.1007/s13760-015-0491-3     Document Type: Article

References (27)

1. Compston A, Coles A (2008) Multiple sclerosis. Lancet 372(9648):1502–1517. doi:10.1016/S0140-6736(08)61620-7
2. Miller E (2012) Multiple sclerosis. Adv Exp Med Biol 724:222–238. doi:10.1007/978-1-4614-0653-2_17
3. Martins TB, Rose JW, Jaskowski TD, Wilson AR, Husebye D, Seraj HS, Hill HR (2011) Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay. Am J Clin Pathol 136(5):696–704. doi:10.1309/AJCP7UBK8IBVMVNR
4. Venken K, Hellings N, Liblau R, Stinissen P (2010) Disturbed regulatory T cell homeostasis in multiple sclerosis. Trends Mol Med 16(2):58–68. doi:10.1016/j.molmed.2009.12.003
5. Jadidi-Niaragh F, Mirshafiey A (2011) Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol 74(1):1–13. doi:10.1111/j.1365-3083.2011.02536.x
6. Hauser SL, Bhan AK, Gilles F, Kemp M, Kerr C, Weiner HL (1986) Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol 19(6):578–587. doi:10.1002/ana.410190610
7. Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, Dalton D, Fathman CG (1996) Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156(1):5–7
8. Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, Klunker S, Meyer N, O’Mahony L, Palomares O, Rhyner C, Ouaked N, Schaffartzik A, Van De Veen W, Zeller S, Zimmermann M, Akdis CA (2011) Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J Allergy Clin Immunol 127(3):701–721. doi:10.1016/j.jaci.2010.11.050(e701–770)
9. Dinarello CA, Bufler P (2013) Interleukin-37. Semin Immunol 25(6):466–468. doi:10.1016/j.smim.2013.10.004
10. Garlanda C, Dinarello CA, Mantovani A (2013) The interleukin-1 family: back to the future. Immunity 39(6):1003–1018. doi:10.1016/j.immuni.2013.11.010
11. Dinarello C, Arend W, Sims J, Smith D, Blumberg H, O’Neill L, Goldbach-Mansky R, Pizarro T, Hoffman H, Bufler P, Nold M, Ghezzi P, Mantovani A, Garlanda C, Boraschi D, Rubartelli A, Netea M, van der Meer J, Joosten L, Mandrup-Poulsen T, Donath M, Lewis E, Pfeilschifter J, Martin M, Kracht M, Muehl H, Novick D, Lukic M, Conti B, Solinger A, Kelk P, van de Veerdonk F, Gabel C (2010) IL-1 family nomenclature. Nat Immunol 11(11):973. doi:10.1038/ni1110-973
12. Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11(11):1014–1022. doi:10.1038/ni.1944
13. Bufler P, Gamboni-Robertson F, Azam T, Kim SH, Dinarello CA (2004) Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem J 381(Pt 2):503–510. doi:10.1042/BJ20040217
14. Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, Mangelberger D, Oostingh GJ, Pfaller T, Pixner C, Posselt G, Italiani P, Nold MF, Nold-Petry CA, Bufler P, Dinarello CA (2011) IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 22(3):127–147. doi:10.1684/ecn.2011.0288
15. Li C, Zhao P, Sun X, Che Y, Jiang Y (2013) Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barre syndrome. Mediators Inflamm 2013:639712. doi:10.1155/2013/639712
16. Song L, Qiu F, Fan Y, Ding F, Liu H, Shu Q, Liu W, Li X (2013) Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus. J Clin Immunol 33(1):111–117. doi:10.1007/s10875-012-9791-z
17. Sharma S, Kulk N, Nold MF, Graf R, Kim SH, Reinhardt D, Dinarello CA, Bufler P (2008) The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J Immunol 180(8):5477–5482
18. Fernandez M, Montalban X, Comabella M (2010) Orchestrating innate immune responses in multiple sclerosis: molecular players. J Neuroimmunol 225(1–2):5–12. doi:10.1016/j.jneuroim.2010.05.014
19. Petek-Balci B, Coban A, Shugaiv E, Turkoglu R, Ulusoy C, Icoz S, Pehlivan M, Tuzun E, Akman-Demir G, Kurtuncu M, Eraksoy M (2014) Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis. Int J Neurosci. doi:10.3109/00207454.2014.939747
20. Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9(6):393–407. doi:10.1038/nri2550
21. Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683–747. doi:10.1146/annurev.immunol.23.021704.115707
22. Chen HM, Fujita M (2015) IL-37: a new player in immune tolerance. Cytokine 72(1):113–114. doi:10.1016/j.cyto.2014.11.025
23. McNamee EN, Masterson JC, Jedlicka P, McManus M, Grenz A, Collins CB, Nold MF, Nold-Petry C, Bufler P, Dinarello CA, Rivera-Nieves J (2011) Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci USA 108(40):16711–16716. doi:10.1073/pnas.1111982108
24. Sakai N, Van Sweringen HL, Belizaire RM, Quillin RC, Schuster R, Blanchard J, Burns JM, Tevar AD, Edwards MJ, Lentsch AB (2012) Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells. J Gastroenterol Hepatol 27(10):1609–1616. doi:10.1111/j.1440-1746.2012.07187.x
25. Bulau AM, Fink M, Maucksch C, Kappler R, Mayr D, Wagner K, Bufler P (2011) In vivo expression of interleukin-37 reduces local and systemic inflammation in concanavalin A-induced hepatitis. Sci World J 11:2480–2490. doi:10.1100/2011/968479
26. Li Y, Wang Z, Yu T, Chen B, Zhang J, Huang K, Huang Z (2014) Increased expression of IL-37 in patients with Graves’ disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells. PLoS One 9(9):e107183. doi:10.1371/journal.pone.0107183
27. Zhao PW, Jiang WG, Wang L, Jiang ZY, Shan YX, Jiang YF (2014) Plasma levels of IL-37 and correlation with TNF-alpha, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PLoS One 9(5):e95346. doi:10.1371/journal.pone.0095346